Cowen and Company’s Alkermes ALKS Stock Holding History

Cowen and Company’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,385	Closed	-$573K	–	580
2021 Q2	$573K	Buy	+23,385	New	+$520K	0.03%	167

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cowen and Company's ALKS Position: Q3 2021 in Review

Cowen and Company sold out of Alkermes (ALKS) in Q3 2021, closing a stake of 23,385 shares — an estimated $573K sold.

Cowen and Company first reported a position in ALKS in Q2 2021 and held it in 1 quarter. The position peaked at $573K in Q2 2021. 224 funds tracked by Wall St. Rank hold ALKS as of Q3 2021.

Cowen and Company reported no remaining Alkermes position as of Q3 2021 after selling out during the quarter.
Cowen and Company sold 23,385 Alkermes shares in Q3 2021, an estimated $573K.
Cowen and Company first reported a position in Alkermes in Q2 2021 and held it in 1 quarter.
Cowen and Company's Alkermes position peaked at $573K in Q2 2021.
224 funds tracked by Wall St. Rank held Alkermes as of Q3 2021.

Based on Cowen and Company's 13F filing for Q3 2021, filed 12 Nov 2021.